Gladstone Institutional Advisory’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,250
Closed -$241K 801
2025
Q2
$241K Sell
3,250
-59
-2% -$4.11K 0.01% 657
2025
Q1
$267K Sell
3,309
-288
-8% -$24.8K 0.01% 613
2024
Q4
$281K Buy
3,597
+15
+0.4% +$1.27K 0.01% 603
2024
Q3
$336K Sell
3,582
-2,204
-38% -$185K 0.02% 548
2024
Q2
$451K Buy
5,786
+827
+17% +$67.5K 0.02% 444
2024
Q1
$451K Buy
4,959
+1,021
+26% +$85K 0.02% 439
2023
Q4
$304K Buy
3,938
+851
+28% +$59.6K 0.02% 520
2023
Q3
$210K Buy
+3,087
New +$225K 0.01% 569

Other funds holding GEHC

Gladstone Institutional Advisory's GEHC Position: Q3 2025 in Review

Gladstone Institutional Advisory sold out of GE HealthCare (GEHC) in Q3 2025, closing a stake of 3,250 shares — an estimated $241K sold.

Gladstone Institutional Advisory first reported a position in GEHC in Q3 2023 and held it in 8 quarters. The position peaked at $451K in Q2 2024. 1,279 funds tracked by Wall St. Rank hold GEHC as of Q3 2025.

  • Gladstone Institutional Advisory reported no remaining GE HealthCare position as of Q3 2025 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 3,250 GE HealthCare shares in Q3 2025, an estimated $241K.
  • Gladstone Institutional Advisory first reported a position in GE HealthCare in Q3 2023 and held it in 8 quarters.
  • Gladstone Institutional Advisory's GE HealthCare position peaked at $451K in Q2 2024.
  • 1,279 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2025.

Based on Gladstone Institutional Advisory's 13F filing for Q3 2025, filed 22 Oct 2025.